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Broad and Specific Caspase
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of Apoptosis in Atherosclerotic Lesions
Evaluated by Radiolabeled Annexin A5 Imaging
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Navneet Narula, MD,* Leo Hofstra, MD, PHD,‡ Frank Kolodgie, PHD,§ Satoshi Isobe, MD,*
Shinichiro Fujimoto, MD,* Jean-Luc Vanderheyden, PHD, Renu Virmani, MD, FACC,§
Chris Reutelingsperger, PHD,‡ Nathan D. Wong, PHD,* Sudhir Gupta, MD, PHD,*
Jagat Narula, MD, PHD, FACC*
Irvine, California; Hannover, Germany; Maastricht, the Netherlands; Gaithersburg, Maryland;
and Boston, Massachusetts
Objectives The purpose of this study was to evaluate the role of caspase inhibitors on acute resolution of apoptosis in
atherosclerotic lesions as evaluated by imaging with annexin A5.
Background Extensive apoptosis of macrophages has been reported at the site of plaque rupture in patients dying of acute coro-
nary syndrome.
Methods Of 31 New Zealand White atherosclerotic rabbits, 6 received broad caspase, 3 received caspase-1, 3 received
caspase-3, 3 received caspase-8, and 4 received caspase-9 inhibitors; 12 animals did not receive any caspase
inhibitors (treatment control group). Six unmanipulated rabbits were used for comparison (disease control
group). Technetium-99m–labeled annexin A5 was used for imaging atherosclerotic lesions; 6 of the 12 uninhib-
ited atherosclerotic rabbits received 99mTc-labeled mutant annexin A5 (radiotracer control group). Gamma im-
ages were obtained, and quantitative radiotracer uptake was compared with pathologic findings.
Results Atherosclerotic lesions were best visible in untreated atherosclerotic rabbits. Quantitative annexin uptake, defined as
the percent of injected dose per g of abdominal aorta tissue, was significantly higher in untreated atherosclerotic ani-
mals (mean  SD  0.0515  0.0099) compared with the normal rabbits (0.0065 0.0008; p  0.0001) or ath-
erosclerotic rabbits receiving mutant annexin (0.014 0.0024; p  0.0001). Among all caspase inhibitor-treated
rabbits, uptake was 39% lower (0.0314 0.0151) than in untreated atherosclerotic animals (p 0.01). Uptake was
also significantly lower in rabbits receiving broad caspase (0.0206 0.0058; p  0.0001) or caspase-1, -3, or -9
(0.0272  0.0088, p  0.01; 0.0286  0.0095, p  0.01; 0.0300  0.0021, p  0.01, respectively) inhibitors.
Caspase-8 inhibitor did not affect apoptosis (0.0618 0.0047; p  NS). Upon histologic characterization, a substan-
tial decrease in macrophage apoptosis was observed in caspase-inhibited animals.
Conclusions Molecular imaging, using radiolabeled annexin A5, allows the detection of acute resolution of apoptosis as a
result of caspase inhibition in experimental atherosclerosis. If proven clinically, this may allow development of
novel intervention strategies in acute vascular events. (J Am Coll Cardiol 2007;50:2305–12) © 2007 by the
American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.08.044t
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eutopsy studies have revealed a high prevalence of apoptosis
n vulnerable and ruptured atherosclerotic plaques, which is
ssociated with activation of caspase-1 and -3 (1,2). Apop-
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Acute Inhibition of Apoptosis in Atheroma December 11, 2007:2305–12large cores are important deter-
minants of plaque vulnerability.
In addition, extensive apoptosis
of foam cells is seen at the site of
fibrous cap rupture (1,2). Thera-
peutic interventions known to
substantially reduce acute coro-
nary events, such as dietary mod-
ification and statin treatment, re-
duce the prevalence of apoptosis
in atherosclerotic lesions (6,7).
However, a recent clinical trial of
high-dose statin treatment, imme-
diately following acute coronary
syndrome, demonstrated that the
enefit of statins may be observed only after a lapse of 4 to 5
eeks, a period when recurrent events are most frequent (8).
herefore, it is logical to assume that if apoptosis contrib-
tes to plaque rupture, acute repression of apoptosis in acute
oronary events should help prevent early recurrent coronary
vents. It should be possible to inhibit apoptosis acutely by
harmacologic interventions targeted at the signaling cas-
ade of apoptosis.
There are 2 major signaling pathways of apoptosis
Fig. 1): the death receptor pathway (9–11) and the mito-
hondrial pathway (12,13). In the death receptor pathway,
he signal is provided by the interaction between the ligand
nd death receptor, recruitment of adapter proteins, and
Abbreviations
and Acronyms
CT  computed
tomography
%ID/g  percent injected
dose per gram
PS  phosphatidylserine
SPECT  single photon
emission computed
tomography
TUNEL  terminal
deoxyribonucleotide
transferase-mediated nick-
end labeling
Figure 1 Pathways of Apoptosis and Possible
Involvement of Caspase-1 in Apoptosis
In the present study, inhibitors of caspase-8 and -9 were used to differentiate
between involvement of the death receptor and mitochondrial pathways of apo-
ptosis. IL  interleukin; ROS  reactive oxygen species.fctivation of proximal (caspase-8) and executioner caspases.
n the mitochondrial signaling pathway, a number of
olecules (including cytochrome c) are released from the
itochondrial intermembrane space into the cytoplasm.
here they interact with adapter proteins and activate a
istinct initiator caspase (caspase-9) that then activates
ommon executioner caspases, resulting in apoptosis.
aspase-3 is a prototype of the executioner caspases, and it
leaves a number of cytoplasmic and nuclear substrates,
hich results in the morphologic and biochemical charac-
eristics of apoptosis (11). Activation of proximal caspases
istinguishes between death receptor (caspase-8) and mito-
hondrial (caspase-9) pathways of apoptosis.
Caspase-3 activation is closely associated with phospha-
idylserine (PS) expression on the apoptotic cell surface (14).
nnexin A5, a naturally occurring protein, binds to PS with
igh affinity and has been used as an early marker of
poptosis. Radiolabeled annexin A5 has been successfully
mployed for the noninvasive detection of macrophage
poptosis in experimental atherosclerotic lesions in rabbit
15) and mouse aorta (16), porcine coronary arteries (17),
nd carotid arteries in patients who had suffered transient
schemic episodes (18).
The present study was performed to evaluate if acute
epression of apoptosis was possible by the using caspase
nhibitors, as determined by noninvasive imaging with
echnetium-99m (99mTc)–labeled annexin A5. For inhi-
ition of apoptosis, we employed intravenously infused
road caspase inhibitors, executioner caspase-3–specific
nhibitor, and inhibitors of proximal caspases-8 and -9 to
istinguish between death receptor and mitochondrial
athways of apoptosis. Inhibitor of caspase-1 was used
ecause activated caspase-1 has been observed in vulnerable
laques and ruptured lesions in patients dying of acute
oronary events (2).
ethods
xperimental protocol. The experimental protocol was
pproved by the Institutional Animal Research and Care
ommittee at the University of California-Irvine. Thirty-
even male New Zealand White rabbits were obtained from
estern Oregon Farm (Philomath, Oregon). After a
-week quarantine, 6 unmanipulated animals were set aside
s disease controls, and they received normal rabbit chow for
6 weeks (Fig. 2). These animals were imaged with 99mTc-
nnexin A5 16 weeks later.
Atherosclerotic lesions were induced in the remaining 31
abbits. These animals were fed a 0.5% cholesterol diet
ustom-mixed in 6% peanut oil. One week after the start of
he high-cholesterol diet, they underwent balloon de-
ndothelialization of their infradiaphragmatic aortas and
ontinued on a high-cholesterol, high-fat diet for 15 addi-
ional weeks (6). Of these, 25 atherosclerotic animals were
maged with 99mTc-annexin A5 at 16 weeks and classified as
ollows. Six of these 25 atherosclerotic animals were imaged
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December 11, 2007:2305–12 Acute Inhibition of Apoptosis in Atheroman the absence of any caspase inhibitor (treatment control),
nd 19 animals received caspase inhibitors. The caspase
nhibitors were administered by intravenous push for 6 h (3
g) and 1 h (4 mg) before radiolabeled annexin A5 injection:
road (nonselective) caspase inhibitor (n  6), caspase-1
nhibitor (n  3), caspase-3 inhibitor (n  3), caspase-8
nhibitor (n  3), or caspase-9 inhibitor (n  4). The
emaining group of 6 atherosclerotic rabbits was imaged with
utant annexin A5 at week 16 (radiotracer control); mutant
nnexin A5 has ineffective PS-binding sites (6).
eagents. We used a cell-permeable nonselective caspase
nhibitor (ZVAD-fmk; BIOMOL International, LP,
lymouth Meeting, Pennsylvania), caspase-1 inhibitor
YVAD-cho; BIOMOL International, LP), caspase-3 in-
ibitor (DEVD-cho; BIOMOL International, LP),
aspase-8 inhibitor (ZIETD-fmk; Calbiochem, San Diego,
alifornia), and caspase-9 inhibitor (ZLEHD-fmk;
IOMOL International, LP) for acute suppression of
poptosis. The inhibitors were dissolved in dimethylsul-
hoxide and diluted with saline for intravenous administra-
ion. For radionuclide imaging, human recombinant an-
exin A5 was obtained from Theseus Imaging Corporation
Boston, Massachusetts), and mutant annexin A5 was from
osa Medics (Maastricht, the Netherlands).
oninvasive imaging of atherosclerotic lesions. RADIO-
ABELING OF ANNEXIN A5 WITH 99MTC. Human recombi-
ant annexin A5 was produced by expression in Escherichia
oli and was labeled with 99mTc, as described (19). Recom-
inant annexin A5 has been shown to retain PS-binding
ctivity equivalent to that of native annexin A5. Before
adiolabeling, annexin A5 was derivatized with the nicotinic
Figure 2 The Timeline and Experimental Design of the Study
Annexin A5 uptake in 19 animals treated with broad and specific caspase inhibito
was compared with 6 animals each of treatment (Rx), disease, and radiotracer cocid analog hydrazinonicotinamide (HYNIC) (AnorMED, oncorporated, Langley, Canada) at a 0.9 mol/mol ratio by
entle mixing. Hydrazinonicotinamide is a bifunctional
olecule with an affinity for lysine residues of proteins on 1
oiety and for the conjugates of 99mTc on the other; the
table complex formed by this molecule does not affect
rotein bioreactivity. For binding 99mTc to the HYNIC-
nnexin A5 conjugate, a reduced tin (stannous ion) and
ricine solution was added to 99mTc pertechnetate with an
liquot of HYNIC-annexin A5 under anoxic conditions.
he final specific radioactivity was 10 to 200 Ci/g
rotein (1 Ci  37 kBq). Thin-layer chromatography
sing the solvent NaCl showed a radiopurity between 92%
nd 97%.
MAGING PROTOCOL. For molecular imaging, each prepara-
ion of annexin A5 (0.1 mg) radiolabeled with 5.5  1.3
Ci of 99mTc was injected into the left marginal ear vein of
abbits. Three hrs later animals were anesthetized with
etamine and xylazine (0.1 mg/ml each, 10:1 vol/vol).
adionuclide imaging was performed using a Vertex PLUS
amma camera (ADAC Laboratories, Milpitas, California)
or planar imaging (n  30) or a dual-head gamma camera
n 7) with micro-computed tomography (CT) X-SPECT
Gamma Medica, Inc., Northridge, California) for SPECT
mages. Planar images of the abdomen were obtained for 30
in in a 128  28 matrix using a 1-mm pinhole collimator.
ingle photon emission computed tomography (SPECT)
mages of the abdomen were acquired in a 64  64 scaffold,
2 steps at 120 s/step on a 140-keV photopeak of 99mTc
ith a 15% window. After SPECT acquisition, a micro-CT
mage of the rabbit abdomen was acquired without moving
he animal position. The micro-CT used an X-ray tube
roups.
rs
ntrol gperating at 50 kVp and 0.8 mA, and images were captured
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Acute Inhibition of Apoptosis in Atheroma December 11, 2007:2305–12or 0.5 s/view for 256 views in 360° rotation. The micro-
PECT images were converted to a 256 256 scaffold, and
icro-CT studies were fused, allowing the achievement of
imultaneous molecular and anatomic information in all
omographic scans in 3 different spatial axes. After in vivo
maging, animals were sacrificed with an overdose of sodium
entobarbital (120 mg/kg). Aortas were carefully dissected,
nd planar images of ex vivo aortas were obtained for 15 min
n a 128  128 matrix using a 1-mm pinhole collimator.
uantitative radiotracer uptake in tissue specimens.
fter ex vivo imaging, each aorta was segmented at 1-cm
ntervals. These segments were weighed and counted in an
utomatic well-type gamma counter (1480 Wizard 3,
allac, Turku, Finland) for determination of the percent
njected annexin dose per gram (%ID/g) of tissue. Biodis-
ribution in the blood, lung, liver, spleen, kidney, and
keletal muscles was also evaluated. Aortas were preserved
or histologic and immunohistochemical investigations, as
eported earlier (15).
istologic assessment of experimental atherosclerosis.
he aortic segments were fixed with HEPES-buffered
ormalin (4%) containing an additional 2 mmol/l Ca2.
istologic and immunohistochemical characterization was
erformed in 10 atherosclerotic (4 untreated and 2 broad
aspase, 1 caspase-1, 2 caspase-8, and 1 caspase-3 inhibited)
nimals and 2 normal controls. Each aorta was segmented at
-cm intervals, and each 1-cm segment was subdivided into
equidistant sections and embedded on edge in paraffin.
he tissue was then dehydrated in a graded series of ethanol.
erial 4-m-thick sections were cut and mounted on charged
lides (Superfrost; Fisher Scientific, Waltham, Massachusetts).
issue sections were stained with hematoxylin-eosin and Mo-
at pentachrome elastin stains. Atherosclerotic lesions were
haracterized using a classification scheme based on the rec-
mmendations of the American Heart Association (20).
For the immunohistochemical characterization of the
ellular composition, primary antibodies directed against
acrophages (using marker RAM-11, dilution 1:200 over-
ight incubation; Dako, Carpinteria, California) and
mooth muscle cells (using a primary antibody against actin
and  isotopes, HHF-35, dilution 1:200 overnight
ncubation; Enzo Biochem, New York, New York) were
mployed as described previously (15). Primary antibodies
ere tracked with a biotinylated link anti-mouse antibody
sing a peroxidase-based labeled streptavidin biotin kit
Dako) and visualized by an 3-amino-9-ethylcarbazole
ubstrate-chromogen system (Dako). The presence of apop-
otic cells was evaluated by histologic detection of DNA
ragmentation by terminal deoxyribonucleotide transferase
dT-mediated nick-end labeling (TUNEL) staining using
n in situ apoptosis detection kit (TACS, Trevigen, Inc.,
aithersburg, Maryland) as described previously (15). A
ositive reaction was visualized with the chromogen sub-
tance diaminobenzidine tinted with CoCl2, which pro-
uces a black reaction product. The sections were counter-
tained with methylgreen (blue-green nuclei). 0tatistical analyses. Based on our previous article (15),
nnexin uptake in untreated atherosclerotic animals was
.054  0.0095 %ID/g. With a sample of 6 untreated
nimals (treatment control group) in the present study, 3
nimals per caspase inhibitor treatment group would pro-
ide 94% power (1-tailed alpha  0.05) to detect a 40%
eduction in annexin uptake (0.0324 %ID/g uptake). We
elt this to be an important magnitude of reduction to
emonstrate, based on our previous observation showing
hronic statin treatment and dietary modification to reduce
nnexin update by this magnitude (6).
The gamma scintillation counts were calculated as %ID/g
f tissue or blood. Results were expressed as mean 
tandard deviation. The Student t test was initially used to
ompare uptake between untreated atherosclerotic rabbits
nd all caspase inhibitor-treated groups combined. To
etermine the statistical significance of differences between
ndividual caspase inhibitor and control groups, 1-way
nalysis of variance was performed followed by Scheffe’s
ost hoc test for multiple comparisons. An alpha level
0.05 after adjustment for multiple comparisons was con-
idered statistically significant.
esults
n vivo annexin imaging. Gamma imaging allowed non-
nvasive visualization of atherosclerotic lesions in the ab-
ominal aorta; best visible were the untreated atheroscle-
otic plaques (Fig. 3). No annexin uptake was observed in
ormal (nonatherosclerotic, disease control) animals. Simi-
arly, no tracer uptake was seen in atherosclerotic rabbits
maged with mutant annexin A5 (radiotracer control).
nnexin uptake was significantly lower in the groups of
nimals treated with broad caspase inhibitor and caspase-3
nhibitor compared with the untreated atherosclerotic rab-
its. Inhibition of caspase-1 and -9 was also associated with
ubstantial reduction in annexin uptake. The uptake was not
ffected in the caspase-8 inhibitor-treated group. The
x vivo gamma images of the explanted aortic specimens
erified the in vivo results.
uantitative annexin A5 uptake in treated and untreated
esions. The quantitative annexin uptake in the atheroscle-
otic specimens, calculated as %ID/g of aortic tissues,
hould represent the extent of apoptotic activity in the
esions. Maximum annexin uptake was observed in the
ntreated atherosclerotic lesions (0.0515  0.0099%),
hich was 10-fold higher than that in the aortic specimens
btained from disease control rabbits (Fig. 4). Among all
aspase inhibitor-treated animals (combining broad and
aspase-1, -3, -8, and -9 groups; n  19), there was an
verall 39% lower annexin uptake (0.0314  0.0151%; p 
.01 compared with untreated atherosclerotic rabbits).
mong individual caspase inhibitor groups, the annexin
ptake was significantly reduced in broad caspase (0.0206
.0058%; p  0.0001) and caspase-3 inhibitor (0.0286 
.0095%; p  0.0034) groups (compared with untreated
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December 11, 2007:2305–12 Acute Inhibition of Apoptosis in Atheromatherosclerotic lesions). Annexin uptake in the broad
aspase inhibitor group was not significantly different than
he annexin uptake in normal aortic specimens (p  NS),
uggesting almost complete (and acute) abrogation of
poptosis in atherosclerotic lesions. The uptake also was
educed markedly in caspase-9 (0.03  0.0021%; p 
.0024) and -1 inhibitor (0.0272  0.0088%; p 
.0016) groups. Annexin uptake remained unchanged for
he caspase-8 inhibitor group (0.0618  0.0047%; p 
S compared with the untreated group and p  0.0001
ompared with the disease control group). Together,
hese data suggest involvement of the mitochondrial
athway of apoptosis in atherosclerosis. Finally, there was
o uptake of mutant annexin in atherosclerotic lesions,
nd quantitative uptake was as low as annexin uptake in
ormal rabbit aortas (0.014  0.0024%; p  NS). The
iodistribution of radiotracer in nontarget organs showed
aximal radiation burden in the renal cortex (6.2  1.1
ID/g), spleen (0.37  0.14%), and liver (0.15 
.05%).
istology of atherosclerotic lesions. Our previous study
ad shown that specific annexin uptake preferentially oc-
urred in the advanced American Heart Association type IV
therosclerotic plaque; the uptake was traced to the apopto-
ic foam cells by dual immunohistochemical staining tech-
Figure 3 Noninvasive Imaging of Apoptosis in Experimentally In
The images were obtained in both control (nonatherosclerotic) and atherosclerotic
onstrates planar gamma images, and the bottom panel presents micro-single pho
ground of micro-CT images. (A) Lack of annexin uptake in the region of the abdom
The annexin metabolism and excretion results in variation burden to liver (L), splee
accumulation can be seen in the abdominal aorta (shown by arrows in front of ver
mals receiving (C) nonselective caspase inhibitor or (D) selective caspase-1 inhib
reveals superimposed nuclear and CT images after treatment with selective caspa
tions, transverse and sagittal. Whereas the caspase-3 inhibitor completely prevent
caspase-8 inhibition did not affect annexin uptake or apoptosis. In caspase-8 inhibiques (15). Similarly, in the present study, the lesions were aredominantly foam cell rich with minimal smooth muscle
ell content and showed extensive apoptosis (Fig. 4). The
nimals treated with the broad caspase inhibitor also
evealed foam cell-rich lesions histopathologically similar
o those in untreated rabbits; however, almost no
UNEL-positive apoptotic nuclei were observed (Fig. 4).
he lipid cores with predominant cholesterol clefts and
bundant macrophages were visible in the lesions and
emained unaffected after administration of caspase in-
ibitors. A similar phenomenon was observed in the
nimals treated with selective caspase-1 and -3 inhibitors.
owever, apoptosis was unaffected in the selective
aspase-8 inhibitor group and was found to be similar to
ntreated animals (Fig. 5).
iscussion
he present study demonstrated the feasibility of acute
esolution of apoptosis in atherosclerotic plaques with broad
nd selective caspase inhibitors. This study also demon-
trated the feasibility of employing radioactive annexin A5
or evaluation of apoptosis resolution by noninvasive imag-
ng. Because apoptosis of macrophages contributes signifi-
antly to plaque rupture, it is logical to presume that acute
epression of apoptosis may be of therapeutic benefit in
d Atherosclerosis With Radiolabeled Annexin A5
o) rabbits with or without caspase (Casp) inhibitor therapy. The top panel dem-
ission computed tomography (CT) images superimposed on a morphologic back-
rta as denoted by arrows in the normal rabbit with no atherosclerotic lesions.
and kidney (K). (B) Compared with the negative control, significant radiotracer
column activity) of the animal with experimental atherosclerotic lesions. The ani-
monstrate total abrogation of annexin uptake. (E and F) The bottom panel
hibitor and caspase-8 inhibitor. The images are present in the set of 2 projec-
nexin A5 uptake (arrows pointing to aortic area in front of vertebral uptake),
eated animals, vivid uptake of radiotracer is seen in the abdominal aorta.duce
(ather
ton em
inal ao
n (S),
tebral
itor de
se-3 in
ed an
itor-trcute coronary events.
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Acute Inhibition of Apoptosis in Atheroma December 11, 2007:2305–12The data support efficacy of broad caspase and caspase-9
nd -3 inhibitors for acute repression of apoptosis in
therosclerosis. Because caspase-8 inhibition had no signif-
cant effect on apoptosis and caspase-9 inhibition signifi-
antly blocked it, the apoptosis of foam cells is likely to
nvolve the mitochondrial pathway and not the death
eceptor pathway. In an earlier in vitro study, caspases-3 and
9 played a critical role in the apoptosis of cultured vascular
mooth muscle cells in atherosclerotic lesions, and the
nhibitors of both caspase-9 and -3 markedly reduced
poptosis (21).
We observed that the caspase-1 inhibitor also blocked
poptosis to a level similar to the broad caspase and specific
aspase-3 inhibitors, suggesting that caspase-1 may also be
nvolved in apoptosis in atherosclerotic lesions (Fig. 1). A
revious autopsy report also demonstrated the role of
aspase-1 activation in acute coronary syndrome (2). Acti-
ation of caspase-1 in apoptosis in atherosclerosis is intrigu-
ng (22,23). The pro-domain of caspase-1 enhances
Figure 4 The Extent of Apoptosis in Various Animal Groups Rep
A5 Uptake and Histologic Characterization of Untreat
The left panel demonstrates the uptake of annexin A5 in abdominal aortas. Disea
and the remaining atherosclerotic animals by solid bars. Atherosclerotic animals im
atherosclerotic animals were either untreated (black bar) or treated with various c
pink, caspase-8 and -9 inhibitors differentiating between mitochondrial and extram
green solid bar. The statistical significance of caspase inhibition, in comparison w
below the bars, respectively. The uptake is significantly higher in the abdominal a
tracer control groups. Treatment with a broad caspase inhibitor or selective caspa
lower annexin uptake. On the other hand, selective caspase-8 inhibition did not af
lesions in atherosclerotic untreated animals and atherosclerotic animals receiving
and macrophage (Ram-11) staining (200) in untreated atherosclerotic animals (l
terol crystal-rich necrotic core, foam cell-rich, and smooth muscle-deficient lesions
erosclerosis are unchanged. However, terminal deoxyribonucleotide transferase-me
untreated atherosclerotic animals but marked resolution in the atherosclerotic lesaspase-8 activation during CD95 (fas)-mediated apoptosis b24), the specific caspase-1 inhibitor blocks CD95-mediated
poptosis in rat acinar cells (25), and caspase-1–deficient
ice are resistant to CD95-mediated apoptosis (26). These
tudies suggested that caspase-1 may be involved in the
eath receptor or extrinsic pathway of apoptosis. However,
e observed no effect of the caspase-8 inhibitor on apoptosis
n atherosclerotic lesions, excluding an involvement of the
xtrinsic pathway. Caspase-1 involvement in the mitochon-
rial pathway of apoptosis has recently been demonstrated
n traumatic brain injuries in children. Increased levels of
ytochrome c, caspase-3, and caspase-1 have been observed
n the cerebrospinal fluid, and caspase-3 and -1 activation
ave been observed in brain tissue (27). It has been proposed
hat reactive oxygen species generation is downstream of
aspase-1 (28,29). Because reactive oxygen species genera-
ion mediates apoptosis via cytochrome c release and acti-
ation of caspase-9 and -3 (30), it is likely that caspase-1
s upstream of caspase-9 and -3. Our data may indirectly
upport these observations because the caspase-1 inhibitor
nted by Quantitative Annexin
d Broad Caspase-Inhibited Animals
trol animals (C) with no atherosclerotic lesions are represented by an open bar
with mutant annexin were used as tracer controls (gray bar), and the remaining
e inhibitors (colored bars). Broad and caspase-3 inhibition bars are shown in
ndrial pathways are in blue, and capase-1–specific inhibition is represented by a
disease control and untreated atherosclerotic animals, is shown above and
f untreated atherosclerotic animals compared with that in the disease and
9, or -3 inhibitor significantly reduced the apoptotic activity as represented by
optosis. The right panel compares histologic characterization of atherosclerotic
oad caspase inhibitor. Movat pentachrome (M5Ch), smooth muscle cell (-actin),
d broad caspase inhibitor-treated animals (right) demonstrate similar choles-
orphologic characteristics of the lesions in untreated and caspase-treated ath-
nick-end labeling (TUNEL) reveals evidence of marked apoptotic nuclei in
caspase-inhibited animals.rese
ed an
se con
aged
aspas
itocho
ith the
ortas o
se-1, -
fect ap
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December 11, 2007:2305–12 Acute Inhibition of Apoptosis in Atheromahe inhibitor of caspase-9. Interestingly, activation of
aspase-11 has been demonstrated during ischemia-induced
poptosis in the brain (31), which was associated with
ubsequent activation of caspase-1 and -3. It is unclear if
here is activation of caspase-11 in experimentally induced
therosclerotic lesions.
Acute resolution of apoptosis may have translational
linical implications. Because extensive apoptosis has
een demonstrated in acute coronary events, acute repres-
ion of apoptosis may offer novel avenues for interven-
ion. Such a proposal may be of added value because
esolution of apoptosis has also been shown to be
eneficial in limiting myocardial injury in experimental
yocardial infarction.
onclusions
he present study indicated that broad and specific
aspase inhibitor therapy can acutely reduce the incidence
f apoptosis in experimental atherosclerotic lesions. A
itochondrial pathway appears to be predominantly in-
olved in induction of apoptosis, and a novel role of
aspase-1 in apoptosis in atherosclerotic lesion is suggested.
f verified in clinical trials, repression of apoptosis by specific
Figure 5 Immunohistologic Characterization of Atherosclerotic
Movat pentachrome (M5Ch), smooth muscle cell (-actin), macrophage (Ram-11),
ing (200) in representative sections of aorta from nonatherosclerotic control ani
caspase (Casp)-1, -3, and -8 inhibitors are shown. The pentachrome stains demon
intense macrophage infiltration and low smooth muscle cell content in all treated
characteristics of the atherosclerotic lesions. The TUNEL staining showed evidenc
caspase-1 and -3 resulted in decreased apoptotic nuclei in neointima; treatment waspase inhibitors may add to intervention strategies incute coronary syndromes. Our findings also support the
alue of annexin A5 imaging as a noninvasive tool to
onitor pharmacologic effects of therapies aimed to reduce
poptosis.
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